Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02639221
Recruitment Status : Completed
First Posted : December 24, 2015
Last Update Posted : September 28, 2016
Information provided by (Responsible Party):
Prexton Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2016
Actual Study Completion Date : September 2016